Thermo Fisher Scientific Inc
NYSE:TMO

Watchlist Manager
Thermo Fisher Scientific Inc Logo
Thermo Fisher Scientific Inc
NYSE:TMO
Watchlist
Price: 513.26 USD -0.55% Market Closed
Market Cap: 196.3B USD
Have any thoughts about
Thermo Fisher Scientific Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Thermo Fisher Scientific Inc

Current Assets 23.8B
Cash & Short-Term Investments 6.6B
Receivables 9.8B
Other Current Assets 7.3B
Non-Current Assets 76.6B
PP&E 9.4B
Intangibles 63B
Other Non-Current Assets 4.2B
Current Liabilities 14.6B
Accounts Payable 2.6B
Accrued Liabilities 5.2B
Other Current Liabilities 6.8B
Non-Current Liabilities 36.8B
Long-Term Debt 31.2B
Other Non-Current Liabilities 5.6B

Balance Sheet
Thermo Fisher Scientific Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 344
452
786
1 335
2 103
2 399
10 325
4 477
8 524
8 077
Cash Equivalents
1 344
452
786
1 335
2 103
2 399
10 325
4 477
8 524
8 077
Short-Term Investments
29
14
16
10
31
37
28
0
2
3
Total Receivables
2 474
2 545
3 427
4 311
4 136
4 952
6 472
8 945
9 427
9 664
Accounts Receivables
2 474
2 545
3 049
3 879
4 136
4 952
6 472
8 945
9 427
9 664
Other Receivables
0
0
378
432
0
0
0
0
0
0
Inventory
1 860
1 992
2 213
2 971
3 005
3 370
4 029
5 051
5 634
5 088
Other Current Assets
835
739
579
794
1 350
1 135
1 103
1 640
1 644
1 760
Total Current Assets
6 540
5 741
7 021
9 421
10 625
11 893
21 957
20 113
25 229
24 589
PP&E Net
2 427
2 449
2 578
4 047
4 165
5 448
6 687
9 864
10 873
11 004
PP&E Gross
2 427
2 449
2 578
4 047
4 165
5 448
6 687
9 864
10 873
11 004
Accumulated Depreciation
1 442
1 665
1 838
2 292
2 655
3 015
3 665
4 260
4 989
6 076
Intangible Assets
14 110
12 758
13 969
16 684
14 978
14 014
12 685
20 113
17 442
16 670
Goodwill
18 843
18 828
21 328
25 290
25 347
25 714
26 041
41 924
41 196
44 020
Note Receivable
0
0
0
0
0
0
0
0
7
4
Long-Term Investments
0
0
0
0
0
0
0
22
55
12
Other Long-Term Assets
933
1 058
1 012
1 227
1 117
1 312
1 682
3 087
2 352
2 427
Other Assets
18 843
18 828
21 328
25 290
25 347
25 714
26 041
41 924
41 196
44 020
Total Assets
42 852
N/A
40 834
-5%
45 908
+12%
56 669
+23%
56 232
-1%
58 381
+4%
69 052
+18%
95 123
+38%
97 154
+2%
98 726
+2%
Liabilities
Accounts Payable
821
822
926
1 428
1 615
1 920
2 175
2 867
3 381
2 872
Accrued Liabilities
1 833
1 717
2 020
2 751
2 436
2 674
4 098
5 377
5 449
4 842
Short-Term Debt
0
0
0
0
0
0
0
2 522
310
0
Current Portion of Long-Term Debt
2 212
1 052
1 256
2 135
1 271
676
2 628
15
5 269
3 609
Other Current Liabilities
484
556
664
734
825
927
1 403
2 655
2 601
2 689
Total Current Liabilities
5 350
4 146
4 866
7 048
6 147
6 197
10 304
13 436
17 010
14 012
Long-Term Debt
12 352
11 420
15 372
18 873
17 719
17 076
19 107
32 333
28 909
31 308
Deferred Income Tax
3 431
2 623
2 557
2 766
2 265
2 192
1 794
3 837
2 849
1 922
Minority Interest
0
0
0
0
0
0
0
184
170
107
Other Liabilities
1 172
1 295
1 573
2 569
2 515
3 241
3 340
4 540
4 238
4 642
Total Liabilities
22 304
N/A
19 484
-13%
24 368
+25%
31 256
+28%
28 646
-8%
28 706
+0%
34 545
+20%
54 330
+57%
53 176
-2%
51 991
-2%
Equity
Common Stock
409
412
415
428
432
434
437
439
441
442
Retained Earnings
10 407
12 142
13 927
15 914
18 696
22 092
28 116
35 431
41 910
47 364
Additional Paid In Capital
11 474
11 801
12 140
14 177
14 621
15 064
15 579
16 174
16 743
17 286
Unrealized Security Profit/Loss
20
25
56
51
52
71
91
35
33
28
Treasury Stock
456
1 008
2 306
3 103
3 665
5 236
6 818
8 922
12 017
15 133
Other Equity
1 265
1 973
2 580
1 952
2 446
2 608
2 716
2 294
3 099
3 224
Total Equity
20 548
N/A
21 350
+4%
21 539
+1%
25 413
+18%
27 586
+9%
29 675
+8%
34 507
+16%
40 793
+18%
43 978
+8%
46 735
+6%
Total Liabilities & Equity
42 852
N/A
40 834
-5%
45 908
+12%
56 669
+23%
56 232
-1%
58 381
+4%
69 052
+18%
95 123
+38%
97 154
+2%
98 726
+2%
Shares Outstanding
Common Shares Outstanding
400
400
393
401
402
399
397
394
391
387

See Also

Discover More